1. Home
  2. BMRA

as of 12-26-2025 2:10pm EST

$2.71
+$0.01
+0.38%
Stocks Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances Nasdaq

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Founded: 1971 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 8.2M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 141.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.50 EPS Growth: N/A
52 Week Low/High: $2.11 - $10.16 Next Earning Date: 01-13-2026
Revenue: $4,884,000 Revenue Growth: -11.35%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered BMRA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 73.83%
73.83%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Biomerica Inc. News

BMRA Breaking Stock News: Dive into BMRA Ticker-Specific Updates for Smart Investing

All BMRA News

Share on Social Networks: